{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:16:58Z","timestamp":1784639818822,"version":"3.55.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12013-021-01013-9","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T08:03:02Z","timestamp":1623830582000},"page":"547-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Genotype\/Phenotype Interactions and First Steps Toward Targeted Therapy for Sphingosine Phosphate Lyase Insufficiency Syndrome"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4894-919X","authenticated-orcid":false,"given":"Julie D.","family":"Saba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Yeu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"1013_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1515\/bchm2.1969.350.2.1233","volume":"350","author":"W Stoffel","year":"1969","unstructured":"Stoffel, W., LeKim, D., & Sticht, G. (1969). Distribution and properties of dihydrosphingosine-1-phosphate aldolase (sphinganine-1-phosphate alkanal-lyase). Hoppe-Seylers Zeitschrift fur Physiologische Chemie, 350, 1233\u20131241.","journal-title":"Hoppe-Seylers Zeitschrift fur Physiologische Chemie"},{"key":"1013_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.advenzreg.2009.10.024","volume":"50","author":"M Serra","year":"2010","unstructured":"Serra, M., & Saba, J. D. (2010). Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. Advances in Enzyme Regulation, 50, 349\u2013362.","journal-title":"Advances in Enzyme Regulation"},{"key":"1013_CR3","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cell.2012.01.038","volume":"148","author":"JE Chipuk","year":"2012","unstructured":"Chipuk, J. E., McStay, G. P., Bharti, A., Kuwana, T., Clarke, C. J., Siskind, L. J., Obeid, L. M., & Green, D. R. (2012). Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell, 148, 988\u20131000.","journal-title":"Cell"},{"key":"1013_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jbior.2016.09.007","volume":"63","author":"DL Ebenezer","year":"2017","unstructured":"Ebenezer, D. L., Fu, P., Suryadevara, V., Zhao, Y., & Natarajan, V. (2017). Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: role of S1P lyase. Advances in Biological Regulation, 63, 156\u2013166.","journal-title":"Advances in Biological Regulation"},{"key":"1013_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/15548627.2017.1291471","volume":"13","author":"DN Mitroi","year":"2017","unstructured":"Mitroi, D. N., Karunakaran, I., Graler, M., Saba, J. D., Ehninger, D., Ledesma, M. D., & van Echten-Deckert, G. (2017). SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production. Autophagy, 13, 885\u2013899.","journal-title":"Autophagy"},{"key":"1013_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbrc.2012.06.012","volume":"424","author":"P Upadhyaya","year":"2012","unstructured":"Upadhyaya, P., Kumar, A., Byun, H. S., Bittman, R., Saba, J. D., & Hecht, S. S. (2012). The sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA. Biochemical and Biophysical Research Communications, 424, 18\u201321.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1013_CR7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.cellsig.2011.02.009","volume":"23","author":"A Kumar","year":"2011","unstructured":"Kumar, A., Byun, H. S., Bittman, R., & Saba, J. D. (2011). The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner. Cellular Signalling, 23, 1144\u20131152.","journal-title":"Cellular Signalling"},{"key":"1013_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/sj.emboj.7601565","volume":"26","author":"K Zhang","year":"2007","unstructured":"Zhang, K., Pompey, J., Hsu, F., Turk, J., Bandhuvula, P., Saba, J., & Beverley, S. (2007). Redirection of sphingolipid metabolism towards de novo synthesis of ethanolamine in Leishmania. EMBO Journal, 26, 1094\u20131104.","journal-title":"EMBO Journal"},{"key":"1013_CR9","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1194\/jlr.M076562","volume":"58","author":"F Schumacher","year":"2017","unstructured":"Schumacher, F., Neuber, C., Finke, H., Nieschalke, K., Baesler, J., Gulbins, E., & Kleuser, B. (2017). The sphingosine 1-phosphate breakdown product, (2E)-hexadecenal, forms protein adducts and glutathione conjugates in vitro. Journal of Lipid Research, 58, 1648\u20131660.","journal-title":"Journal of Lipid Research"},{"key":"1013_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/imr.12760","volume":"289","author":"D Dixit","year":"2019","unstructured":"Dixit, D., Okuniewska, M., & Schwab, S. R. (2019). Secrets and lyase: control of sphingosine 1-phosphate distribution. Immunological Review, 289, 173\u2013185.","journal-title":"Immunological Review"},{"key":"1013_CR11","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1126\/science.279.5356.1552","volume":"279","author":"MJ Lee","year":"1998","unstructured":"Lee, M. J., Van Brocklyn, J. R., Thangada, S., Liu, C. H., Hand, A. R., Menzeleev, R., Spiegel, S., & Hla, T. (1998). Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science, 279, 1552\u20131555.","journal-title":"Science"},{"key":"1013_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/imm.12272","volume":"142","author":"CS Garris","year":"2014","unstructured":"Garris, C. S., Blaho, V. A., Hla, T., & Han, M. H. (2014). Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond. Immunology, 142, 347\u2013353.","journal-title":"Immunology"},{"key":"1013_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature02284","volume":"427","author":"M Matloubian","year":"2004","unstructured":"Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004). Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature, 427, 355\u2013360.","journal-title":"Nature"},{"key":"1013_CR14","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.1113640","volume":"309","author":"S Schwab","year":"2005","unstructured":"Schwab, S., Pereira, J., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. (2005). Lymphocyte sequestration through S1P lyase inhibition an disruption of S1P gradients. Science, 309, 1735\u20131739.","journal-title":"Science"},{"key":"1013_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd4099","volume":"12","author":"GT Kunkel","year":"2013","unstructured":"Kunkel, G. T., Maceyka, M., Milstien, S., & Spiegel, S. (2013). Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nature Reviews Drug Discovery, 12, 688\u2013702.","journal-title":"Nature Reviews Drug Discovery"},{"key":"1013_CR16","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/nm.2250","volume":"16","author":"H Lee","year":"2010","unstructured":"Lee, H., Deng, J., Kujawski, M., Yang, C., Liu, Y., Herrmann, A., Kortylewski, M., Horne, D., Somlo, G., Forman, S., Jove, R., & Yu, H. (2010). STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nature Medicine, 16, 1421\u20131428.","journal-title":"Nature Medicine"},{"key":"1013_CR17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nature09128","volume":"465","author":"SE Alvarez","year":"2010","unstructured":"Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., Milstien, S., & Spiegel, S. (2010). Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature, 465, 1084\u20131088.","journal-title":"Nature"},{"key":"1013_CR18","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1176709","volume":"325","author":"NC Hait","year":"2009","unstructured":"Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., & Spiegel, S. (2009). Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science, 325, 1254\u20131257.","journal-title":"Science"},{"key":"1013_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/381800a0","volume":"381","author":"O Cuvillier","year":"1996","unstructured":"Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., & Spiegel, S. (1996). Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381, 800\u2013803.","journal-title":"Nature"},{"key":"1013_CR20","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1074\/jbc.273.5.2910","volume":"273","author":"O Cuvillier","year":"1998","unstructured":"Cuvillier, O., Rosenthal, D. S., Smulson, M. E., & Spiegel, S. (1998). Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide- mediated apoptosis in Jurkat T lymphocytes. Journal of Biological Chemistry, 273, 2910\u20132916.","journal-title":"Journal of Biological Chemistry"},{"key":"1013_CR21","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/S0960-9822(00)00834-4","volume":"10","author":"P Xia","year":"2000","unstructured":"Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A., Wattenberg, B. W., D\u2019Andrea, R. J., & Vadas, M. A. (2000). An oncogenic role of sphingosine kinase. Current Biology, 10, 1527\u20131530.","journal-title":"Current Biology"},{"key":"1013_CR22","doi-asserted-by":"publisher","first-page":"9346","DOI":"10.1158\/0008-5472.CAN-09-2198","volume":"69","author":"S Colie","year":"2009","unstructured":"Colie, S., Van Veldhoven, P. P., Kedjouar, B., Bedia, C., Albinet, V., Sorli, S. C., Garcia, V., Djavaheri-Mergny, M., Bauvy, C., Codogno, P., Levade, T., & Andrieu-Abadie, N. (2009). Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2\/Bcl-xL upregulation. Cancer Research, 69, 9346\u20139353.","journal-title":"Cancer Research"},{"key":"1013_CR23","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1172\/JCI74188","volume":"124","author":"E Degagn\u00e9","year":"2014","unstructured":"Degagn\u00e9, E., Pandurangan, A., Bandhuvula, A., Kumar, A., Eltanawy, A., Zhang, M., Yoshinaga, Y., Nefedov, M., de Jong, P., Fong, L., Young, S., Bittman, R., Ahmedi, Y., & Saba, J. (2014). Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. Journal of Clinical Investigation, 124, 5368\u20135384.","journal-title":"Journal of Clinical Investigation"},{"key":"1013_CR24","doi-asserted-by":"publisher","first-page":"17384","DOI":"10.1073\/pnas.0600050103","volume":"103","author":"B Oskouian","year":"2006","unstructured":"Oskouian, B., Sooriyakumaran, P., Borowsky, A., Crans, A., Dillard-Telm, L., Tam, Y., Bandhuvula, P., & Saba, J. (2006). Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is downregulated in colon cancer. Proceedings of the National Academy of Sciences of the United States America, 103, 17384\u201317389.","journal-title":"Proceedings of the National Academy of Sciences of the United States America"},{"key":"1013_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1165\/rcmb.2010-0422OC","volume":"45","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y., Gorshkova, I. A., Berdyshev, E., He, D., Fu, P., Ma, W., Su, Y., Usatyuk, P. V., Pendyala, S., Oskouian, B., Saba, J. D., Garcia, J. G., & Natarajan, V. (2011). Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression. American Journal of Respiratory Cell and Molecular Biology, 45, 426\u2013435.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"1013_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1158\/1541-7786.MCR-04-0197","volume":"3","author":"J Min","year":"2005","unstructured":"Min, J., Van Veldhoven, P. P., Zhang, L., Hanigan, M. H., Alexander, H., & Alexander, S. (2005). Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Molecular Cancer Research, 3, 287\u2013296.","journal-title":"Molecular Cancer Research"},{"key":"1013_CR27","doi-asserted-by":"crossref","unstructured":"Ihlefeld, K., Claas, R. F., Koch, A., Pfeilschifter, J. M., & Meyer Zu Heringdorf, D. (2012). Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. Biochemistry Journal, 447, 457\u2013464.","DOI":"10.1042\/BJ20120811"},{"key":"1013_CR28","doi-asserted-by":"publisher","first-page":"26087","DOI":"10.1074\/jbc.272.42.26087","volume":"272","author":"JD Saba","year":"1997","unstructured":"Saba, J. D., Nara, F., Bielawska, A., Garrett, S., & Hannun, Y. A. (1997). The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase. Journal of Biological Chemistry, 272, 26087\u201326090.","journal-title":"Journal of Biological Chemistry"},{"key":"1013_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbrc.2004.10.036","volume":"325","author":"M Ikeda","year":"2004","unstructured":"Ikeda, M., Kihara, A., & Igarashi, Y. (2004). Sphingosine-1-phosphate lyase (SPL) is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5\u2019-phosphate binding domain exposed to the cytosol. Biochemical and Biophysical Research Communication, 325, 338\u2013343.","journal-title":"Biochemical and Biophysical Research Communication"},{"key":"1013_CR30","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.str.2010.05.011","volume":"18","author":"F Bourquin","year":"2010","unstructured":"Bourquin, F., Riezman, H., Capitani, G., & Grutter, M. G. (2010). Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism. Structure, 18, 1054\u20131065.","journal-title":"Structure"},{"key":"1013_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1194\/jlr.S091181","volume":"60","author":"JD Saba","year":"2019","unstructured":"Saba, J. D. (2019). Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease. Journal of Lipid Research, 60, 456\u2013463.","journal-title":"Journal of Lipid Research"},{"key":"1013_CR32","unstructured":"Weaver, K. N., Sullivan, B., Hildebrandt, F., Strober, J., Cooper, M., Prasad, R., & Saba, J. (2020). Sphingosine phosphate lyase insufficiency syndrome. In Adam, M. P., Ardinger, H. H., Pagon, R. A., Wallace, S.E., Bean, L. J. H., Stephens, K., & Amemiya, A. (Eds.), GeneReviews\u00ae [Internet]. Seattle, WA: University of Washington, Seattle; 1993\u20132021. 15 Oct 2020."},{"key":"1013_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1172\/JCI89626","volume":"127","author":"S Lovric","year":"2017","unstructured":"Lovric, S., Goncalves, S., Gee, H. Y., Oskouian, B., Srinivas, H., Choi, W. I., Shril, S., Ashraf, S., Tan, W., Rao, J., Airik, M., Schapiro, D., Braun, D. A., Sadowski, C. E., Widmeier, E., Jobst-Schwan, T., Schmidt, J. M., Girik, V., Capitani, G., Suh, J. H., Lachaussee, N., Arrondel, C., Patat, J., Gribouval, O., Furlano, M., Boyer, O., Schmitt, A., Vuiblet, V., Hashmi, S., Wilcken, R., Bernier, F. P., Innes, A. M., Parboosingh, J. S., Lamont, R. E., Midgley, J. P., Wright, N., Majewski, J., Zenker, M., Schaefer, F., Kuss, N., Greil, J., Giese, T., Schwarz, K., Catheline, V., Schanze, D., Franke, I., Sznajer, Y., Truant, A. S., Adams, B., Desir, J., Biemann, R., Pei, Y., Ars, E., Lloberas, N., Madrid, A., Dharnidharka, V. R., Connolly, A. M., Willing, M. C., Cooper, M. A., Lifton, R. P., Simons, M., Riezman, H., Antignac, C., Saba, J. D., & Hildebrandt, F. (2017). Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency. Journal of Clinical Investigation, 127, 912\u2013928.","journal-title":"Journal of Clinical Investigation"},{"key":"1013_CR34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1172\/JCI90171","volume":"127","author":"R Prasad","year":"2017","unstructured":"Prasad, R., Hadjidemetriou, I., Maharaj, A., Meimaridou, E., Buonocore, F., Saleem, M., Hurcombe, J., Bierzynska, A., Barbagelata, E., Bergada, I., Cassinelli, H., Das, U., Krone, R., Hacihamdioglu, B., Sari, E., Yesilkaya, E., Storr, H. L., Clemente, M., Fernandez-Cancio, M., Camats, N., Ram, N., Achermann, J. C., Van Veldhoven, P. P., Guasti, L., Braslavsky, D., Guran, T., & Metherell, L. A. (2017). Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. Journal of Clinical Investigation, 127, 942\u2013953.","journal-title":"Journal of Clinical Investigation"},{"key":"1013_CR35","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3174\/ajnr.A6746","volume":"41","author":"KW Martin","year":"2020","unstructured":"Martin, K. W., Weaver, N., Alhasan, K., Gumus, E., Sullivan, B. R., Zenker, M., Hildebrandt, F., & Saba, J. D. (2020). MRI spectrum of brain involvement in sphingosine-1-phosphate lyase insufficiency syndrome. American Journal of Neuroradiology, 41, 1943\u20131948.","journal-title":"American Journal of Neuroradiology"},{"key":"1013_CR36","doi-asserted-by":"crossref","unstructured":"Zhao, P., Liu, I. D., Hodgin, J. B., Benke, P. I., Selva, J., Torta, F., Wenk, M. R., Endrizzi, J. A., West, O., Ou, W., Tang, E., Goh, D. L., Tay, S. K., Yap, H. K., Loh, A., Weaver, N., Sullivan, B., Larson, A., Cooper, M. A., Alhasan, K., Alangari, A. A., Salim, S., Gumus, E., Chen, K., Zenker, M., Hildebrandt, F., & Saba, J. D. (2020). Responsiveness of sphingosine phosphate lyase insufficiency syndrome to vitamin B6 cofactor supplementation. Journal of Inherited Metabolic Disease, 43, 1131\u20131142.","DOI":"10.1002\/jimd.12238"},{"key":"1013_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/humu.23192","volume":"38","author":"AR Janecke","year":"2017","unstructured":"Janecke, A. R., Xu, R., Steichen-Gersdorf, E., Waldegger, S., Entenmann, A., Giner, T., Krainer, I., Huber, L. A., Hess, M. W., Frishberg, Y., Barash, H., Tzur, S., Schreyer-Shafir, N., Sukenik-Halevy, R., Zehavi, T., Raas-Rothschild, A., Mao, C., & Muller, T. (2017). Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications. Human Mutation, 38, 365\u2013372.","journal-title":"Human Mutation"},{"key":"1013_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1212\/WNL.0000000000003595","volume":"88","author":"D Atkinson","year":"2017","unstructured":"Atkinson, D., Nikodinovic Glumac, J., Asselbergh, B., Ermanoska, B., Blocquel, D., Steiner, R., Estrada-Cuzcano, A., Peeters, K., Ooms, T., De Vriendt, E., Yang, X. L., Hornemann, T., Milic Rasic, V., & Jordanova, A. (2017). Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy. Neurology, 88, 533\u2013542.","journal-title":"Neurology"},{"key":"1013_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.braindev.2018.02.008","volume":"40","author":"D Bamborschke","year":"2018","unstructured":"Bamborschke, D., Pergande, M., Becker, K., Koerber, F., Dotsch, J., Vierzig, A., Weber, L. T., & Cirak, S. (2018). A novel mutation in sphingosine-1-phosphate lyase causing congenital brain malformation. Brain Development, 40, 480\u2013483.","journal-title":"Brain Development"},{"key":"1013_CR40","doi-asserted-by":"crossref","unstructured":"Settas, N., Persky, R., Faucz, F. R., Sheanon, N., Voutetakis, A., Lodish, M., Metherell, L. A., & Stratakis, C. A. (2018). SGPL1 deficiency: a rare cause of primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism, 104, 1484\u20131490.","DOI":"10.1210\/jc.2018-02238"},{"key":"1013_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fped.2020.00151","volume":"8","author":"A Maharaj","year":"2020","unstructured":"Maharaj, A., Theodorou, D., Banerjee, I. I., Metherell, L. A., Prasad, R., & Wallace, D. (2020). A sphingosine-1-phosphate lyase mutation associated with congenital nephrotic syndrome and multiple endocrinopathy. Frontiers in Pediatrics, 8, 151.","journal-title":"Frontiers in Pediatrics"},{"key":"1013_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00467-018-3982-7","volume":"34","author":"S Saygili","year":"2019","unstructured":"Saygili, S., Canpolat, N., Sever, L., Caliskan, S., Atayar, E., & Ozaltin, F. (2019). Persistent hypoglycemic attacks during hemodialysis sessions in an infant with congenital nephrotic syndrome: answers. Pediatric Nephrology, 34, 77\u201379.","journal-title":"Pediatric Nephrology"},{"key":"1013_CR43","doi-asserted-by":"crossref","unstructured":"Linhares, N. D., Arantes, R. R., Araujo, S. A., & Pena, S. D. J. (2018). Nephrotic syndrome and adrenal insufficiency caused by a variant in SGPL1. Clinical Kidney Journal, 11, 462\u2013467.","DOI":"10.1093\/ckj\/sfx130"},{"key":"1013_CR44","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1084\/jem.20160287","volume":"213","author":"J Zamora-Pineda","year":"2016","unstructured":"Zamora-Pineda, J., Kumar, A., Suh, J., Zhang, M., & Saba, J. (2016). Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. Journal of Experimental Medicine, 213, 2773\u20132791.","journal-title":"Journal of Experimental Medicine"},{"key":"1013_CR45","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1177\/0192623314565650","volume":"43","author":"J Schumann","year":"2015","unstructured":"Schumann, J., Grevot, A., Ledieu, D., Wolf, A., Schubart, A., Piaia, A., Sutter, E., Cote, S., Beerli, C., Pognan, F., Billich, A., Moulin, P., & Walker, U. J. (2015). Reduced activity of sphingosine-1-phosphate lyase induces podocyte-related glomerular proteinuria, skin irritation, and platelet activation. Toxicologic Pathology, 43, 694\u2013703.","journal-title":"Toxicologic Pathology"},{"key":"1013_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","volume":"11","author":"AB Fogo","year":"2015","unstructured":"Fogo, A. B. (2015). Causes and pathogenesis of focal segmental glomerulosclerosis. Nature Reviews Nephrology, 11, 76\u201387.","journal-title":"Nature Reviews Nephrology"},{"key":"1013_CR47","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1681\/ASN.2008050549","volume":"20","author":"D Schlondorff","year":"2009","unstructured":"Schlondorff, D., & Banas, B. (2009). The mesangial cell revisited: no cell is an island. Journal of the American Society of Nephrology, 20, 1179\u20131187.","journal-title":"Journal of the American Society of Nephrology"},{"key":"1013_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep37064","volume":"6","author":"DN Mitroi","year":"2016","unstructured":"Mitroi, D. N., Deutschmann, A. U., Raucamp, M., Karunakaran, I., Glebov, K., Hans, M., Walter, J., Saba, J., Graler, M., Ehninger, D., Sopova, E., Shupliakov, O., Swandulla, D., & van Echten-Deckert, G. (2016). Sphingosine 1-phosphate lyase ablation disrupts presynaptic architecture and function via an ubiquitin\u2013proteasome mediated mechanism. Scientific Reports, 6, 37064.","journal-title":"Scientific Reports"},{"key":"1013_CR49","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/cdd.2011.7","volume":"18","author":"N Hagen","year":"2011","unstructured":"Hagen, N., Hans, M., Hartmann, D., Swandulla, D., & van Echten-Deckert, G. (2011). Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. Cell Death and Differentiation, 18, 1356\u20131365.","journal-title":"Cell Death and Differentiation"},{"key":"1013_CR50","doi-asserted-by":"publisher","first-page":"11346","DOI":"10.1074\/jbc.M807336200","volume":"284","author":"N Hagen","year":"2009","unstructured":"Hagen, N., Van Veldhoven, P. P., Proia, R. L., Park, H., Merrill, Jr, A. H., & Van Echten-Deckert, G. (2009). Subcellular origin of sphingosine-1-phosphate is essential for its toxic effect in lyase deficient neurons. Journal of Biological Chemistry, 284, 11346\u201311353.","journal-title":"Journal of Biological Chemistry"},{"key":"1013_CR51","doi-asserted-by":"crossref","unstructured":"Zhao, P., Tassew, G. B., Lee, J. Y., Oskouian, B., Munoz, D. P., Hodgin, J. B., Watson, G. L., Tang, F., Wang, J. Y., Luo, J., Yang, Y., King, S. M., Krauss, R. M., Keller, N., & Saba, J. D. (2021). Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome. JCI Insight, 6, e145936.","DOI":"10.1172\/jci.insight.145936"},{"key":"1013_CR52","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1194\/jlr.M028084","volume":"53","author":"AD Borowsky","year":"2012","unstructured":"Borowsky, A. D., Bandhuvula, P., Kumar, A., Yoshinaga, Y., Nefedov, M., Fong, L. G., Zhang, M., Baridon, B., Dillard, L., de Jong, P., Young, S. G., West, D. B., & Saba, J. D. (2012). Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues. Journal of Lipid Research, 53, 1920\u20131931.","journal-title":"Journal of Lipid Research"},{"key":"1013_CR53","doi-asserted-by":"publisher","first-page":"e4112","DOI":"10.1371\/journal.pone.0004112","volume":"4","author":"P Vogel","year":"2009","unstructured":"Vogel, P., Donoviel, M. S., Read, R., Hansen, G. M., Hazlewood, J., Anderson, S. J., Sun, W., Swaffield, J., & Oravecz, T. (2009). Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS ONE, 4, e4112.","journal-title":"PLoS ONE"},{"key":"1013_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1523-1747.2000.00846.x","volume":"114","author":"M Behne","year":"2000","unstructured":"Behne, M., Uchida, Y., Seki, T., de Montellano, P. O., Elias, P. M., & Holleran, W. M. (2000). Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. Journal of Investigative Dermatology, 114, 185\u2013192.","journal-title":"Journal of Investigative Dermatology"},{"key":"1013_CR55","doi-asserted-by":"publisher","first-page":"105730","DOI":"10.1016\/j.jsbmb.2020.105730","volume":"202","author":"A Maharaj","year":"2020","unstructured":"Maharaj, A., Williams, J., Bradshaw, T., Guran, T., Braslavsky, D., Casas, J., Chan, L. F., Metherell, L. A., & Prasad, R. (2020). Sphingosine-1-phosphate lyase (SGPL1) deficiency is associated with mitochondrial dysfunction. The Journal of Steroid Biochemistry and Molecular Biology, 202, 105730.","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"1013_CR56","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1074\/jbc.M309646200","volume":"279","author":"U Reiss","year":"2004","unstructured":"Reiss, U., Oskouian, B., Zhou, J., Gupta, V., Sooriyakumaran, P., Kelly, S., Wang, E., Merrill, Jr, A. H., & Saba, J. D. (2004). Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. Journal of Biological Chemistry, 279, 1281\u20131290.","journal-title":"Journal of Biological Chemistry"},{"key":"1013_CR57","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/pedi.12513","volume":"18","author":"S Morikawa","year":"2017","unstructured":"Morikawa, S., Tajima, T., Nakamura, A., Ishizu, K., & Ariga, T. (2017). A novel heterozygous mutation of the WFS1 gene leading to constitutive endoplasmic reticulum stress is the cause of Wolfram syndrome. Pediatric Diabetes, 18, 934\u2013941.","journal-title":"Pediatric Diabetes"},{"key":"1013_CR58","doi-asserted-by":"crossref","unstructured":"Straub, I. R., Weraarpachai, W., & Shoubridge, E. A. (2021). Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses. Human Molecular Genetics, 30, 687\u2013705.","DOI":"10.1093\/hmg\/ddab078"},{"key":"1013_CR59","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.bbapap.2014.12.028","volume":"1854","author":"RS Phillips","year":"2015","unstructured":"Phillips, R. S. (2015). Chemistry and diversity of pyridoxal-5\u2019-phosphate dependent enzymes. Biochimica et Biophysica Acta, 1854, 1167\u20131174.","journal-title":"Biochimica et Biophysica Acta"},{"key":"1013_CR60","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.clinbiochem.2013.11.021","volume":"47","author":"B Cellini","year":"2014","unstructured":"Cellini, B., Montioli, R., Oppici, E., Astegno, A., & Voltattorni, C. B. (2014). The chaperone role of the pyridoxal 5\u2019-phosphate and its implications for rare diseases involving B6-dependent enzymes. Clinical Biochemistry, 47, 158\u2013165.","journal-title":"Clinical Biochemistry"},{"key":"1013_CR61","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10545-005-0243-2","volume":"29","author":"PT Clayton","year":"2006","unstructured":"Clayton, P. T. (2006). B6-responsive disorders: a model of vitamin dependency. Journal of Inherited Metabolic Disease, 29, 317\u2013326.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1013_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/A:1010319001722","volume":"24","author":"N Gregersen","year":"2001","unstructured":"Gregersen, N., Bross, P., Andrese, B. S., Pedersen, C. B., Corydon, T. J., & Bolund, L. (2001). The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders. Journal of Inherited Metabolic Disease, 24, 189\u2013212.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1013_CR63","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J","volume":"14","author":"P Bross","year":"1999","unstructured":"Bross, P., Corydon, T. J., Andresen, B. S., Jorgensen, M. M., Bolund, L., & Gregersen, N. (1999). Protein misfolding and degradation in genetic diseases. Human Mutation, 14, 186\u2013198.","journal-title":"Human Mutation"},{"key":"1013_CR64","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/ajt.12706","volume":"14","author":"EC Lorenz","year":"2014","unstructured":"Lorenz, E. C., Lieske, J. C., Seide, B. M., Meek, A. M., Olson, J. B., Bergstralh, E. J., & Milliner, D. S. (2014). Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant. American Journal of Transplantation, 14, 1433\u20131438.","journal-title":"American Journal of Transplantation"},{"key":"1013_CR65","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jimd.12060","volume":"42","author":"MP Wilson","year":"2019","unstructured":"Wilson, M. P., Plecko, B., Mills, P. B., & Clayton, P. T. (2019). Disorders affecting vitamin B6 metabolism. Journal of Inherited Metabolic Disease, 42, 629\u2013646.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1013_CR66","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13052-017-0387-3","volume":"43","author":"R Falsaperla","year":"2017","unstructured":"Falsaperla, R., & Corsello, G. (2017). Pyridoxine dependent epilepsies: new therapeutical point of view. Italian Journal of Pediatrics, 43, 68.","journal-title":"Italian Journal of Pediatrics"},{"key":"1013_CR67","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/pro.679","volume":"20","author":"F Bourquin","year":"2011","unstructured":"Bourquin, F., Capitani, G., & Grutter, M. G. (2011). PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism. Protein Science, 20, 1492\u20131508.","journal-title":"Protein Science"},{"key":"1013_CR68","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nrg963","volume":"3","author":"RJ Desnick","year":"2002","unstructured":"Desnick, R. J., & Schuchman, E. H. (2002). Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. Nature Reviews Genetics, 3, 954\u2013966.","journal-title":"Nature Reviews Genetics"},{"key":"1013_CR69","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1038\/mtna.2015.37","volume":"4","author":"XH Zhang","year":"2015","unstructured":"Zhang, X. H., Tee, L. Y., Wang, X. G., Huang, Q. S., & Yang, S. H. (2015). Off-target effects in CRISPR\/Cas9-mediated genome engineering. Molecular Therapy-Nucleic Acids, 4, e264.","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"1013_CR70","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","volume":"79","author":"SM Hoy","year":"2019","unstructured":"Hoy, S. M. (2019). Onasemnogene Abeparvovec: first global approval. Drugs, 79, 1255\u20131262.","journal-title":"Drugs"},{"key":"1013_CR71","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.hoc.2017.06.007","volume":"31","author":"T Athanasopoulos","year":"2017","unstructured":"Athanasopoulos, T., Munye, M. M., & Yanez-Munoz, R. J. (2017). Nonintegrating gene therapy vectors. Hematology\/Oncology Clinics of North America, 31, 753\u2013770.","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"1013_CR72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ng1922","volume":"39","author":"J Schmahl","year":"2007","unstructured":"Schmahl, J., Raymond, C. S., & Soriano, P. (2007). PDGF signaling specificity is mediated through multiple immediate early genes. Nature Genetics, 39, 52\u201360.","journal-title":"Nature Genetics"},{"key":"1013_CR73","doi-asserted-by":"publisher","first-page":"10880","DOI":"10.1074\/jbc.M109.081489","volume":"285","author":"M Bektas","year":"2010","unstructured":"Bektas, M., Allende, M. L., Lee, B. G., Chen, W., Amar, M. J., Remaley, A. T., Saba, J. D., & Proia, R. L. (2010). Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. Journal of Biological Chemistry, 285, 10880\u201310889.","journal-title":"Journal of Biological Chemistry"},{"key":"1013_CR74","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1074\/jbc.M110.171819","volume":"286","author":"M Allende","year":"2011","unstructured":"Allende, M., Bektas, M., Lee, B., Bonifacino, E., Kang, J., Tuymetova, G., Chen, W., Saba, J., & Proia, R. (2011). Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. Journal of Biological Chemistry, 286, 7348\u20137358.","journal-title":"Journal of Biological Chemistry"},{"key":"1013_CR75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jconrel.2016.09.011","volume":"241","author":"J Saraiva","year":"2016","unstructured":"Saraiva, J., Nobre, R. J., & Pereira de Almeida, L. (2016). Gene therapy for the CNS using AAVs: the impact of systemic delivery by AAV9. Journal of Controlled Release, 241, 94\u2013109.","journal-title":"Journal of Controlled Release"},{"key":"1013_CR76","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1172\/JCI125297","volume":"130","author":"CJ Studstill","year":"2020","unstructured":"Studstill, C. J., Pritzl, C. J., Seo, Y. J., Kim, D. Y., Xia, C., Wolf, J. J., Nistala, R., Vijayan, M., Cho, Y. B., Kang, K. W., Lee, S. M., & Hahm, B. (2020). Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence. Journal of Clinical Investigation, 130, 6523\u20136538.","journal-title":"Journal of Clinical Investigation"},{"key":"1013_CR77","doi-asserted-by":"crossref","unstructured":"Meacci, E., & Garcia-Gil, M. (2019). S1P\/S1P receptor signaling in neuromuscolar disorders. International Journal of Molecular Sciences 20, 6364.","DOI":"10.3390\/ijms20246364"},{"key":"1013_CR78","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1515\/jpem-2011-0296","volume":"27","author":"IL Pezzuti","year":"2014","unstructured":"Pezzuti, I. L., Silva, I. N., Albuquerque, C. T., Duarte, M. G., & Silva, J. M. (2014). Adrenal insufficiency in association with congenital nephrotic syndrome: a case report. Journal of Pediatric Endocrinology and Metabolism, 27, 565\u2013567.","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"1013_CR79","doi-asserted-by":"publisher","first-page":"13129","DOI":"10.1111\/jcmm.15917","volume":"24","author":"X Du","year":"2020","unstructured":"Du, X., Yang, Y., Zhan, X., Huang, Y., Fu, Y., Zhang, Z., Liu, H., Zhang, L., Li, Y., Wen, Q., Zhou, X., Zuo, D., Zhou, C., Li, L., Hu, S., & Ma, L. (2020). Vitamin B6 prevents excessive inflammation by reducing accumulation of sphingosine-1-phosphate in a sphingosine-1-phosphate lyase-dependent manner. Journal of Cellular and Molecular Medicine, 24, 13129\u201313138.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1013_CR80","doi-asserted-by":"publisher","first-page":"e22436","DOI":"10.1371\/journal.pone.0022436","volume":"6","author":"A Huwiler","year":"2011","unstructured":"Huwiler, A., Bourquin, F., Kotelevets, N., Pastukhov, O., Capitani, G., Grutter, M. G., & Zangemeister-Wittke, U. (2011). A prokaryotic S1P lyase degrades extracellular S1P in vitro and in vivo: implication for treating hyperproliferative disorders. PLoS ONE, 6, e22436.","journal-title":"PLoS ONE"},{"key":"1013_CR81","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.phrs.2016.09.025","volume":"113","author":"WS Chew","year":"2016","unstructured":"Chew, W. S., Wang, W., & Herr, D. R. (2016). To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling. Pharmacological Research, 113, 521\u2013532.","journal-title":"Pharmacological Research"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-021-01013-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-021-01013-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-021-01013-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T10:20:44Z","timestamp":1635330044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-021-01013-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1007\/s12013-021-01013-9","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"7 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"J.D.S. is an inventor on a pending patent application \u201cInternational Application Serial No. PCT\/US2021\/018613 Entitled: Adeno-Associated Viral (Aav)-Mediated <i>Sgpl1<\/i> Gene Therapy for Treatment of Sphingosine-1-Phosphate Lyase Insufficiency Syndrome (Splis)\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}